City of Hope Study Shows Promise for Germline BRCA1/2 Testing in Unselected Breast Cancer Patients
Researchers tallied pathogenic or likely pathogenic germline BRCA1/2 variants within and across ethnicity groups in more than 2,400 diverse, unselected breast cancer patients.
genomeweb.com